Availability and Appropriateness of Allogeneic Bone Marrow Transplantation for Chronic Myeloid Leukemia in 10 Countries
Authors:
- Marcia G. CrosseMCMarcia G. Crosse
- Eric A. PetersonEPEric A. Peterson
- Richard C. WestonRWRichard C. Weston
- Mary M. HorowitzMHMary M. Horowitz
- Frederick R. AppelbaumFAFrederick R. Appelbaum
- Bruce D. ChesonBCBruce D. Cheson
- 20 October 1994
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 331 (16) , 1063-1067
Abstract
Allogeneic bone marrow transplantation, a sophisticated and expensive procedure, is the only curative therapy for chronic myeloid leukemia (CML). We examined the availability and appropriateness of allogeneic bone marrow transplantation for CML in 10 economically advanced countries with diverse health care systems. For each country we obtained data on the likelihood of transplantation to treat CML in patients under the age of 55 years, the length of time from diagnosis to transplantation, and the stage of disease at the time of transplantation.Keywords
This publication has 14 references indexed in Scilit:
- Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid LeukemiaNew England Journal of Medicine, 1994
- Bone marrow transplantation in Europe: major geographical differencesJournal of Internal Medicine, 1993
- Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor ProgramNew England Journal of Medicine, 1993
- Increasing Utilization of Allogeneic Bone Marrow TransplantationAnnals of Internal Medicine, 1992
- INCREASING UTILIZATION OF BONE MARROW TRANSPLANTATIONTransplantation, 1989
- Prospective confirmation of a prognostic classification for Ph + chronic myeloid leukaemiaBritish Journal of Haematology, 1988
- Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic PhaseAnnals of Internal Medicine, 1988
- INCREASING UTILIZATION OF BONE MARROW TRANSPLANTATIONTransplantation, 1986
- Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantationBlood, 1985
- ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKAEMIAThe Lancet, 1984